Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Recent & Breaking News (TSXV:RX)

BioSyent Schedules Q1 2017 Earnings Release for May 25, 2017

Marketwired May 16, 2017

FeraMAX(R) Named #1 by Canadian Physicians and Pharmacists for Second Consecutive Year

Marketwired May 1, 2017

BioSyent to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference

MarketWire Canada April 24, 2017

BioSyent Extends In-License Agreement for Cathejell(R)

Marketwired April 20, 2017

BioSyent Releases Results for Fourth Quarter and Full Year 2016

MarketWire Canada March 15, 2017

BioSyent Schedules Fourth Quarter 2016 Earnings Release for March 15, 2017

Marketwired March 6, 2017

BioSyent Announces Sale of Shares

MarketWire Canada December 12, 2016

BioSyent Releases Results for Third Quarter and First Nine Months of 2016

MarketWire Canada November 23, 2016

BioSyent Pharma Launches New Urgent Care Product

MarketWire Canada November 14, 2016

BioSyent Signs Exclusive Agreement for New Women's Health Product

MarketWire Canada November 8, 2016

BioSyent Schedules Q3 2016 Earnings Release for November 23, 2016

MarketWire Canada November 7, 2016

BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies With a Five-Year Revenue Growth Rate of 815%

MarketWire Canada September 15, 2016

BioSyent Releases Q2 and H1 2016 Results

MarketWire Canada August 12, 2016

BioSyent Schedules Q2 2016 Earnings Release for August 12, 2016

MarketWire Canada August 8, 2016

Almadex Discovers Gold-Rich Porphyry System at Norte Target, El Cobre Project, Mexico: Hits 163.50 Meters of 0.68 g/t Gold and 0.29% Copper Including 43.00 Meters of 1.61 g/t Gold and 0.41% Copper to 317.00 Meters, Assays Pending for Rest of Hole

MarketWire Canada August 8, 2016

BioSyent Releases Q1 2016 Results

MarketWire Canada May 27, 2016

FeraMAX(R) Named #1 by Canadian Doctors and Pharmacists

MarketWire Canada May 26, 2016

IIROC Trading Resumption - RX

Canada NewsWire May 25, 2016

IIROC Trade Resumption - BioSyent Inc.

Newsfile May 25, 2016

BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products

MarketWire Canada May 25, 2016